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ABSTRACT Although cell membranes normally resist the hydrolytic action of secretory phospholipase A2 (sPLA2), they become
susceptible during apoptosis or after cellular trauma. Experimentally, susceptibility to the enzyme can be induced by loading cells
with calcium. In humanerythrocytes, the ability of the calcium ionophore to cause susceptibility depends on temperature, occurring
best above ;35C. Considerable evidence from experiments with artiﬁcial bilayers suggests that hydrolysis of membrane lipids
requires two steps. First, the enzyme adsorbs to the membrane surface, and second, a phospholipid diffuses from the membrane
into the active site of the adsorbed enzyme. Analysis of kinetic experiments suggested that this mechanism can explain the action
of sPLA2 on erythrocyte membranes and that temperature and calcium loading promote the second step. This conclusion was
further supported by binding experiments and assessment of membrane lipid packing. The adsorption of ﬂuorescent-labeled
sPLA2 was insensitive to either temperature or ionophore treatment. In contrast, the ﬂuorescence of merocyanine 540, a probe
sensitive to lipid packing, was affected by both. Lipid packing decreased modestly as temperature was raised from 20 to 60C.
Calcium loading enhanced packing at temperatures in the low end of this range, but greatly reduced packing at higher
temperatures. This result was corroborated bymeasurements of the rate of extraction of a ﬂuorescent phosphatidylcholine analog
from erythrocyte membranes. Furthermore, drugs known to inhibit susceptibility in erythrocytes also prevented the increase in
phospholipid extraction rate. These results argue that the two-step model applies to biological as well as artiﬁcial membranes and
that a limiting step in the hydrolysis of erythrocyte membranes is the ability of phospholipids to migrate into the active site of
adsorbed enzyme.
INTRODUCTION
Secretory phospholipase A2 (sPLA2) has been studied for
many years as a model for the action of an enzyme at a lipid/
water interface. Several investigations have suggested that
the action of the enzyme on membrane surfaces requires two
steps (Scheme 1, reviewed in Gelb et al., 1995; Jain and
Berg, 1989). The ﬁrst step consists of adsorption of sPLA2 to
the membrane surface. The second step involves binding of
phospholipid molecules in the active site of the adsorbed
enzyme (Gelb et al., 1995; Jain and Berg, 1989; Bell and
Biltonen, 1989). The second step also has a direct require-
ment for calcium as a cofactor and can be inhibited by
replacing calcium with barium (Dam-Mieras et al., 1975; Yu
et al., 1993a, 1998). Either or both steps may be limiting for
artiﬁcial bilayers that are resistant to sPLA2, but certain
perturbations to membrane structure, such as increased
microheterogeneity or negative charge at the membrane
surface, overcome such limitations (Jain et al., 1989; Burack
and Biltonen, 1994; Honger et al., 1996; Henshaw et al.,
1998; Yu et al., 2000; Tatulian, 2001; Bezzine et al., 2002).
We propose that the action of sPLA2 on biological mem-
branes involves the same two steps. Normally, cell mem-
branes resist hydrolysis by the enzyme (Smith et al., 2001;
Wilson et al., 1999; Nielson et al., 2000). However, under
certain conditions, such as during apoptosis or after cellular
trauma, they become highly susceptible (Smith et al., 2001;
Wilson et al., 1999; Judd et al., 2003; Nielson et al., 2000;
Atsumi et al., 1997). We have used human erythrocytes as
a model to study the factors governing membrane suscep-
tibility to sPLA2 (Vest et al., 2004; Smith et al., 2001; Harris
et al., 2001; Best et al., 2002). Experimentally, loading the
cells with calcium via an ionophore can induce susceptibility
to the enzyme. This effect of calcium is indirect and separate
from its role as a catalytic cofactor as described above.
Apparently, this indirect effect of calcium involves changes
in membrane physical properties that lead to an increase in
the extent of boundaries between domains of ordered and
disordered lipids (Vest et al., 2004; Smith et al., 2001; Harris
et al., 2001; Best et al., 2002). The hypothesis was proposed
that phospholipid-neighbor interactions are weakened at
these boundaries, allowing phospholipids in those regions to
migrate from their normal position in the bilayer into the
enzyme active site (Best et al., 2002; Smith et al., 2001).
To test this hypothesis more explicitly, we have examined
two predictions that should occur when the membrane is
susceptible: the second step in the hydrolysis scheme should
be enhanced, and the packing of membrane lipids at domain
boundaries should be reduced. These predictions were ex-
plored with kinetic measurements of membrane hydrolysis,
assessment of membrane adsorption by ﬂuorescent-labeled
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sPLA2, and by the ﬂuorescence of two probes: merocyanin
540 (MC540) and a ﬂuorescent phospholipid analog, 2-(6-
(7-nitrobenz-2-oxa-1 3-diazol-4-yl)amino)hexanoyl-1-hexa-
decanoyl-sn-glycero-3-phosphocholine (NBD-PC). MC540
binds to the outer leaﬂet of cell membranes (Sieber, 1987)
and detects subtle differences in membrane packing revealed
by a 20-nm red-shift in emission maximum as lipids become
less tightly packed (Langner and Hui, 1993; Stillwell et al.,
1993; Yu and Hui, 1992). NBD-PC has been used exten-
sively to study the behavior of membrane phospholipids
(reviewed in Chattopadhyay, 1990) and functions as a sub-
strate for sPLA2 (Meyuhas et al., 1992).
MATERIALS AND METHODS
Reagents
Erythrocytes were obtained from individuals receiving blood tests during
physical examinations at the Brigham Young University Student Health
Center, stored overnight at 4C and prepared for experiments in modiﬁed
balanced salt solution (MBSS; 134 mM NaCl, 6.2 mM KCl, 1.6 mM CaCl2,
1.2 mM MgCl2, 18 mM HEPES, 13.6 mM glucose, pH 7.4 at 37C) as
explained previously in Smith et al. (2001).
Active monomeric aspartate 49 sPLA2 and the inactive lysine 49 form
(AppK49) from the venom of Agkistrodon piscivorus piscivorus were
isolated according to the published procedure of Maraganore et al. (1984).
Prior studies have veriﬁed that this enzyme behaves qualitatively the same as
human groups IIa and V sPLA2 in the types of experiments described in this
report (Wilson et al., 1999; Smith et al., 2001). Stock solutions of the
enzyme (0.1 to 1.2 mg/ml) were prepared in 50 mM KCl with 3 mM NaN3
and stored at 4C.
Ionomycin was purchased from Calbiochem (La Jolla, CA) and dissolved
in dimethylsulfoxide (DMSO) for experiments. Control experiments using
DMSO instead of ionomycin demonstrated that the solvent had no effect on
the experimental results reported in this article or on cell morphology or
membrane physical properties (assessed by two-photon microscopy). The
DMSO concentration in samples after addition of ionomycin was 0.25%
(v/v). Furthermore, controls in which calcium in the cell medium had been
replaced with EDTA demonstrated that ﬂuorescence measurements of mem-
brane properties were due to calcium entry into the cell rather than artifacts
resulting from direct effects of ionomycin on cell membranes.
NBD-PC and MC540 were obtained from Molecular Probes (Eugene,
OR). Bovine serum albumin (BSA; 96–99%, fraction V) was purchased
from Sigma (St. Louis, MO). R5421 was a gift of Jeffrey T. Billheimer at
Dupont Merck Pharmaceutical (Wilmington, DE). Other reagents were
obtained from standard sources.
Merocyanine 540 ﬂuorescence
Emission spectra of MC540 were acquired (emission, 550–700 nm; exci-
tation, 540 nm, 4–16 nm bandpass, depending on sample intensity) with a
Fluoromax (Jobin Yvon Horiba, Edison, NJ) or PC-1 (ISS, Champaign, IL)
photon-counting spectroﬂuorometer at temperatures ranging from 20.0 to
60.0C. Sample homogeneity was maintained by continuous gentle stirring
with a magnetic stir bar. MC540 (0.3 mM ﬁnal) was added to 2 ml MBSS in
a ﬂuorometer sample cell and incubated for 5 min at the desired temperature
before obtaining an initial spectrum as an aqueous reference. Washed
erythrocytes (ﬁnal density of ;3–4 3 106 cells/ml) were then added to the
sample, and a second emission spectrum was acquired after sufﬁcient time
had passed for the MC540 to reach equilibrium with the cells (varying from
5 to 20 min, depending on the temperature). Ionomycin (300 nM ﬁnal) was
ﬁnally added, and a third spectrum was attained after 10 min. Difference
spectra were calculated by subtracting the aqueous reference spectrum from
each of the spectra obtained in the presence of cells (i.e., both before and
after ionomycin treatment).
Membrane hydrolysis by sPLA2
Release of free fatty acids from erythrocytes was assayed with ADIFAB (65
nM ﬁnal; excitation, 390 nm; emission, 432 nm and 505 nm) as described in
Harris et al. (2001) and Richieri and Kleinfeld (1995). Washed erythrocytes
were suspended as in the experiment with MC540. After initiating data
acquisition, ADIFABwas added at 30 s, followed by ionomycin (300 nM) or
DMSO at 130 s, and sPLA2 (21700 nM) at 730 s. Hydrolysis results were
quantiﬁed by calculating the generalized polarization (GP) and estimating
the initial hydrolysis rate at the 20-s time point by nonlinear regression as
described in Harris et al. (2001).
Two-photon excitation scanning microscopy
Scanning two-photon excitation microscopy images were collected on an
Axiovert 35 inverted microscope (Zeiss, Thornwood, NY) with temperature
control at the Laboratory for Fluorescence Dynamics (Urbana, Il), as de-
scribed previously in Harris et al. (2001), Smith et al. (2001), and Yu et al.
(1996). Laser emission was 780 nm at 70–100 mW for ﬂuorescamine ex-
periments and 940 nm at 35–40 mW for NBD-PC.
Phospholipid extraction
NBD-PC was incorporated into the cell membrane using a modiﬁed protocol
of Williamson et al. (1992). NBD-PC (dissolved in ethanol) was dried by
evaporation with nitrogen gas in a glass test tube. An appropriate volume
of MBSS (generally 1–3 ml) was added to the tube, and the dried ﬁlm of
NBD-PC (13 mM, ﬁnal) was suspended by vigorous agitation on a vortex
mixer. Three parts of this suspension was incubated with one-part washed
erythrocytes (3–4 3 107 cells/ml ﬁnal, ;2 3 108 NBD molecules/cell)
for 30 min in the dark at ambient temperature. After incubation, cells were
washed again and resuspended in 2 ml fresh MBSS at a density of 3–43 106
for experiments.
Phospholipid release was assayed by ﬂuorescence spectroscopy using
BSA or sPLA2 as the phospholipid acceptor (see above for ﬂuorometer
details). NBD-PC-labeled cells were incubated for 5 min at temperatures
indicated in Figs. 6–12 before initiating acquisition of the ﬂuorescence
emission intensity (excitation, 485 nm; emission, 535 nm). Either ionomycin
(300 nM ﬁnal) or an equivalent volume of the solvent, DMSO, was added at
120 s.
For extraction with BSA, 150 ml of 10% BSA (0.7% ﬁnal) was added at
720 s, and the data were ﬁt to the following equation by nonlinear regression
starting from the time of addition of BSA,
Y ¼ Að1 eBtÞ1Cð1 eDtÞ1 I; (1)
where A and C represent the magnitude of ﬂuorescence change and B and D
are the rate constants for slow and fast components of change. Control experi-
ments adding BSA to samples of unlabeled erythrocytes or erythrocytes
from which NBD-PC had already been extracted were used to assess artifacts
caused by dilution or optical changes contributed by the BSA addition. The
intercept I accounted quantitatively for these artifacts. Data are expressed as
a normalized derivative evaluated at t ¼ 0 s:
SCHEME 1 Reaction scheme for the interaction of sPLA2 with cell
membranes. E, sPLA2; EB, sPLA2 adsorbed to available sites (MS) on the
membrane surface; S, substrate (membrane phospholipid); ESB, active
enzyme (sPLA2 adsorbed to the membrane surface with phospholipid
bound to the active site); kcat, rate constant of hydrolysis; P, product.
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dY
dt0
¼ AB1CD
Y300
: (2)
Y300 is the total amount of ﬂuorescence change evaluated at 300 s (i.e., at
steady state). Some experiments included various drugs with known effects
on the ability of sPLA2 to hydrolyze erythrocyte membranes. For high KCl
treatment, normal MBSS was replaced in all steps with MBSS containing
89 mM KCl and 51 mM NaCl. EDTA treatments used MBSS containing
20 mM EDTA in lieu of calcium. For trials with the scramblase inhibitor,
R5421 (50 mMﬁnal) was added to the samples incubating in the ﬂuorometer
10 min before either DMSO or ionomycin. Phenylhydrazine (freshly dis-
solved in DMSO before each experiment; 0.5 mM ﬁnal) was added to
samples immediately before DMSO or ionomycin.
For extraction with sPLA2, 20 ml of 7 mM sPLA2 was added at 720 s
(70 nM, ﬁnal) instead of BSA. In this case, no optical artifact occurred upon
addition of the enzyme. The data were ﬁt by nonlinear regression to Eq. 15
(Results).
Secretory PLA2 adsorption to erythrocytes
sPLA2 was labeled with ﬂuorescamine by incubating the enzyme (1.4 mM)
in 2 ml MBSS with 34 ml of a 3 mg/ml stock solution of ﬂuorescamine
dissolved fresh in acetone. Control experiments in which additional un-
labeled enzyme was added veriﬁed that labeling was complete under these
conditions after the ﬂuorescence intensity (excitation, 390 nm; emission,
485 nm) had increased to a stable level (;10 min). Washed erythrocytes
were suspended in MBSS in which CaCl2 and MgCl2 were replaced with
2 mMBaCl2 to allow enzyme adsorption to the membrane surface but impair
membrane hydrolysis (Dam-Mieras et al., 1975; Yu et al., 1993a, 1998). In
experiments testing the effect of ionomycin, cells were suspended in normal
MBSS to which 20 mM BaCl2 was added to prevent hydrolysis but still
allow calcium to enter the cell and cause the membrane changes associated
with susceptibility. Control experiments revealed that these two expectations
were met under our conditions. Additional controls testing the ability of
ﬂuorescamine-labeled sPLA2 to hydrolyze erythrocytes with or without
ionomycin treatment demonstrated that the behavior of the labeled enzyme
was comparable to the native protein.
Adsorption was assayed by either two-photon microscopy or a centrifu-
gation assay. For two-photon microscopy, 1 ml of erythrocytes (3–4 3 106/
ml) was equilibrated with ionomycin (300 nM) or equivalent DMSO for at
least 5 min. Baseline images were then acquired to account for cell intrinsic
ﬂuorescence. Labeled sPLA2 (67 or 130 nM ﬁnal) was added to samples and
additional images were acquired. In some cases, repeated images of the same
ﬁeld were acquired before and after enzyme. This method had the advantage
of assessing repeatedly the intensity of the same cells. However, repeated
exposure to the laser led to elevated cell autoﬂuorescence. This auto-
ﬂuorescence was quantiﬁed and subtracted from the data. Since this effect
could represent laser-induced damage to cells, we also repeated the
experiment using images of different ﬁelds of cells to avoid this potential
difﬁculty. This second method produced data with more variation (because
more ﬁelds were assessed), but the results were comparable to those
obtained repeatedly from the same ﬁeld without the problem of auto-
ﬂuorescence. Experiments from both protocols were pooled for the statistical
analysis of adsorption described in the text. Finally, some experiments
included unlabeled sPLA2 (1.0–2.5 mM active or AppK49) added either
before or after labeled enzyme to test for the ability of the enzymes to
compete for adsorption.
Quantitative analysis involved assessing the increase in image ﬂuores-
cence intensity after addition of labeled sPLA2. The contribution of laser-
exposure-dependent autoﬂuorescence in multiple images of the same ﬁeld
was estimated by linear regression of image intensity during four con-
secutive acquisition sessions before addition of labeled sPLA2. The re-
gression line was then extrapolated to the ﬁfth session, which was acquired
after enzyme addition. This extrapolated intensity was used as the blank to
be subtracted from the data. When images before and after addition of
labeled enzyme involved different ﬁelds, the ﬂuorescence intensity was
assessed for each individual cell in the ﬁelds. The difference in average
intensity per cell was then calculated for the images before and after enzyme
exposure.
Cells were similarly prepared and incubated with DMSO or ionomycin
for the centrifugation assay. In this case, samples were treated in micro-
centrifuge tubes instead of microscopy dishes. Also, cell (6–7 3 106/ml),
labeled-enzyme (130 nM), and ionomycin (550 nM) concentrations were
increased to improve signal size. Labeled sPLA2 was then added, and the
incubation continued for 10 min at the experimental temperature. Cells were
then isolated by rapid centrifugation (15 s at 13,000 3 g), washed in 1 ml
ice-cold MBSS, and centrifuged again. The supernatant was discarded, and
the pellet suspended in 2 ml fresh MBSS and the ﬂuorescence intensity
assessed at 25C by ﬂuorescence spectroscopy (excitation, 390 nm;
emission, 400–600 nm). Blank samples contained cells without labeled
sPLA2, and the total signal was determined from an aliquot of the original
supernatant. Results were analyzed by subtracting the intensity of blank
samples from those containing labeled enzyme. These were then compared
to the total signal to ascertain the percentage of enzyme adsorbed.
Statistical analysis
In all summaries of multiple replicates, the data are expressed as the mean6
SE. Matched-pair t-tests were performed on each treatment pairing the trials
that used blood from the same donor; otherwise unpaired t-tests were used.
All t-tests were two-tailed. Multiple comparisons were conducted using
analysis of variance. Trends were analyzed by linear regression. In every
case, the null hypothesis was rejected when p , 0.05.
MODEL
The model describing the action of sPLA2 on the surface of
membranes is shown in Scheme 1. The rate of hydrolysis
(dP/dt) is given by
dP
dt
¼ kcatESB: (3)
Experiments were conducted in which the concentration of
cells and, therefore, the total number of adsorption sites for
the enzyme (MST) were kept constant. The equilibrium con-
stants (K1 and K2) are deﬁned as
K1 ¼ EBðEÞðMSÞ; (4)
K2 ¼ E
S
B
ðEBÞðSÞ: (5)
If we conﬁne our analysis to the initial part of the hydrolysis
time course, then S can be assumed to be a constant mole
fraction of MST (S0). Since S0 is a constant, we can deﬁne an
apparent equilibrium constant (K92) that is proportional to K2
and can be used in our calculations as
K
0
2 ¼
E
S
B
EB
: (6)
The distribution of membrane binding sites between occu-
pied and unoccupied states is given by
MST ¼ MS1EB1ESB: (7)
If we assume that only a small fraction of added enzyme
adsorbs to the cell surface, then E can be approximated by
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the total enzyme concentration, ET. The validity of this
assumption was veriﬁed by binding experiments described
below. An explicit description of the initial hydrolysis rate
can be obtained by combining Eqs. 3, 4, 6, 7, and 8, as
dP
dt
¼ aETK1K92
11ETK11ETK1K92
; (8)
where a is the apparent hydrolysis rate constant expressed in
units of ADIFAB GP and is proportional to kcat MST.
RESULTS
Hydrolysis kinetics
Contributions of the two steps in Scheme 1 can be
distinguished by varying enzyme concentration and mea-
suring the initial rate of hydrolysis (see Eq. 8). Fig. 1 A
displays the results of that experiment. The hydrolysis rate of
cellular membranes increased signiﬁcantly upon loading the
cells with calcium using the ionophore ionomycin (trian-
gles). This increase in rate was apparent at all sPLA2
concentrations: a two-way analysis of variance estimated
that treatment with ionomycin accounted for 34.3% of the
total variation (p , 0.0001) and increasing the enzyme
concentration accounted for 14.1% of the total variation (p¼
0.008). Statistical interaction between the two variables was
not signiﬁcant (p ¼ 0.76).
Equation 8 was used in a global nonlinear regression
analysis of the data collected for Fig. 1 A. We assumed that a
(i.e., representative of kcat) was not dependent upon mem-
brane changes provoked by ionomycin reasoning that once
a phospholipid has moved out of the membrane and into
the active site of the enzyme, it is no longer affected by the
membrane properties that determine susceptibility. We,
therefore, constrained a to remain equal between the two
conditions (ionomycin-treated cells and control cells).
Table 1 shows the results of the global analysis. Changing
the membrane properties by increasing intracellular calcium
ampliﬁed the equilibrium constant for the ﬁrst step (K1) by
a factor of 2 and the equilibrium constant for the second step
(K29) by a factor of 4. In other words, the afﬁnity of sPLA2
for the cellular membrane doubled and the probability of
a phospholipid moving into the active site of the enzyme
quadrupled. Because K1 is a second-order equilibrium
constant and K92 is a pseudo-ﬁrst-order constant, an increase
in the latter by a factor of 4 contributes much more quan-
titatively to the results of Fig. 1 A than does the doubling of
the adsorption constant. Fig. 1 B illustrates this observation
by displaying the effects of increasing each step separately.
The solid curve indicates the initial hydrolysis rate of control
cells (squares); an increase in the value of K1 by the factor of
2 is indicated by the dotted line; an increase of K92 by a factor
of 4 is indicated by a dashed line. Clearly, the change in K92
explained the majority of the effect of ionomycin treatment
on the susceptibility of the erythrocytes to sPLA2.
This analysis assumed that the same total amount of sub-
strate was accessible to the enzyme under all experimental
conditions. This assumption was validated by experiments in
which cells were incubated with the enzyme for up to 10,000
s. After these extensive incubation periods, it was clear that
the same amount of substrate was hydrolyzed regardless of
enzyme concentration or ionomycin treatment (not shown).
Thus, the effect of ionomycin on erythrocytes was to en-
hance the rate of hydrolysis rather than the amount of sub-
strate available.FIGURE 1 Effect of ionomycin treatment on the enzyme-concentration
dependence of the initial rate of hydrolysis of erythrocytes. (A) Various
concentrations sPLA2 were added to ionomycin-treated (triangles) or
control (DMSO-treated) erythrocytes (squares) and the initial rate of
hydrolysis assessed at 37C as explained in Materials and Methods. Each
datum represents the mean 6 SE of data from ﬁve to seven blood samples.
The curves represent global nonlinear regression of the data using Eq. 8. In
A, the value of a was held constant, and K1 and K
9
2 were allowed to vary
(values summarized in Table 1). In B, the components of the ﬁt for
ionomycin-treated samples in A were altered individually from control
values. (Solid curve, same ﬁt for control samples as in A; dotted curve, the
value of K1 was increased by a factor of 2; dashed curve, the value of K
9
2 was
increased by a factor of 4.)
TABLE 1 Values of constants from Eq. 8 as obtained for
nonlinear regressions in Figs. 1 and 2
Parameter values
Condition a (GP/s1) K1 (mM
1) K92
22.6C, ionomycin (Fig. 2) 0.0027 6.8 0.94
37.0C, DMSO (Fig. 1) 0.0045 8.5 0.71
37.0C, ionomycin (Fig. 1) 0.0045 17.5 2.89
43.5C, ionomycin (Fig. 2) 0.0048 4.0 5.17
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The ability of ionomycin to cause membrane changes and
induce susceptibility to sPLA2 has been shown to be
temperature-sensitive, with mechanistic signiﬁcance attrib-
uted to that sensitivity (Best et al., 2002). Accordingly, we
repeated the experiment of Fig. 1 using erythrocytes treated
with ionomycin at low (22.6C) and high (43.5C) tem-
perature (Fig. 2 A). The effects of enzyme concentration
(24.2% of the variation, p, 0.0001) and temperature (66.6%
of the variation, p , 0.0001) were both signiﬁcant by two-
way analysis of variance. In this case, a signiﬁcant in-
teraction was observed between the variables (5% of the
variation, p ¼ 0.006), suggesting that both the height and
shape of the curve were inﬂuenced by temperature. For
analysis of these data, we did not assume that a would be
constant. In fact, we expected a to increase with temperature
due to the activation energy (DGz) of the catalytic step
according to the Arrhenius equation (R is the gas constant
and T is absolute temperature):
a2
a1
¼ exp DG
z
R
1
T2
 1
T1
  
: (9)
To estimate the activation energy independent of the effects
of membrane physical changes, we assayed the temperature-
dependence of hydrolysis of a short-chain substrate that
forms micelles rather than bilayers. Furthermore, we con-
ducted the experiments at substrate concentrations well
above the critical micelle concentration to avoid temperature
effects on micelle-monomer equilibrium. Fig. 2 B displays
an Arrhenius analysis of the hydrolysis of the short-chain
substrate. The apparent positive slope in the data among the
ﬁrst three data points (54.3–44.3C) was not defensible
statistically, and we therefore chose to analyze the entire data
set as a single unit by linear regression. This assumption of
a monotonic relationship is further justiﬁed by the ob-
servation that the enzyme does not appear to lose activity
or denature until well above temperature range in Fig. 2
(Honger et al., 1996; Best et al., 2002; Singh and Chang,
2004). The activation energy from this analysis was 5.1 6
2.2 kcal/mol, suggesting that the value of a should increase
by a factor of 1.78 between 22.6 and 43.5C based on Eq. 9.
This increase in hydrolysis rate due to the apparent activation
energy was insufﬁcient to account for the fourfold en-
hancement of activity displayed in Fig. 2 A. Accordingly, to
ascertain the source of the additional temperature depen-
dence, a global analysis was conducted using the same
method as in Fig. 1 but accounting for the 1.78-fold change
in a. As illustrated in Table 1, the primary residual effect of
temperature on hydrolysis rate was an increase in the value
of K92 (in fact, the value of K1 actually decreased in the
analysis).
The temperature data with erythrocytes summarized in
Fig. 2 and Table 1 represented only samples treated with
ionomycin. To ascertain whether the temperature-depen-
dence described by these data sets applied solely to the effect
of ionomycin, we repeated the analysis with control samples.
At the same two temperatures, the rate of hydrolysis of
control samples increased by a factor of 1.42 at 70 nM sPLA2
and 1.65 at 700 nM (not shown). These results demonstrated
that all of the temperature-dependence in hydrolysis rate
observed in the absence of ionomycin was due to the acti-
vation energy. Thus, the complete effect of temperature on
erythrocyte sensitivity to sPLA2 can be explained by acti-
vation energy plus the temperature-dependence of the action
of ionomycin. This result supports a hypothesis proposed
previously by Best et al. (2002).
Adsorption of sPLA2 to the membrane surface
The results of the kinetic analysis suggested that effects of
temperature and calcium loading on the ﬁrst step, enzyme
adsorption to the membrane, were minimal. We sought
additional evidence regarding that observation by attempting
to assess directly the adsorption of the enzyme to the cell
surface. Such experiments are complicated by the fact that
not all adsorption visualized experimentally necessarily
represents productive binding that can produce hydrolysis.
FIGURE 2 Effect of temperature on the enzyme-concentration depen-
dence of the initial rate of hydrolysis of ionomycin-treated erythrocytes. (A)
The experiment of Fig. 1 was repeated for ionomycin-treated samples at
22.6C (solid triangles) or 43.5C (open triangles). Each datum represents
the mean6 SE of three separate blood samples. (B) The hydrolysis of 1 mM
dioctanoylphosphatidylcholine micelles (cmc ¼ ;0.3 mM; Heerklotz and
Epand, 2001) was assessed using the same methodology as described for
erythrocyte hydrolysis (70 nM sPLA2). Each datum represents the mean 6
SE of 3–5 samples. The temperatures indicated are the average of the actual
sample temperatures for each point (all within 62.5C).
2696 Jensen et al.
Biophysical Journal 88(4) 2692–2705
An extreme example is the fact that the enzyme can bind to
membrane carbohydrates and protein receptors (Ancian et al.,
1995; Koduri et al., 1998). Nevertheless, our sole objective
was to determine whether ionomycin treatment and/or tem-
perature altered adsorption to the membrane; thus, we felt
justiﬁed in proceeding, notwithstanding this caveat.
To study the adsorption of sPLA2 to the cellular mem-
brane, we labeled the enzyme with ﬂuorescamine, a ﬂuo-
rescent probe that covalently binds to primary amines
(Udenfriend et al., 1972). Fig. 3 illustrates two-photon ﬂuo-
rescence microscopy images of erythrocytes before and after
adding ﬂuorescamine-labeled enzyme under conditions at
which step 2, and thus hydrolysis, was inhibited (in the
presence of barium (Dam-Mieras et al., 1975; Yu et al.,
1993a, 1998). The ﬂuorescence intensity did not decrease
after adding unlabeled enzyme (Fig. 3 C), indicating either
that desorption of sPLA2 from the cellular membrane was
very slow or that the enzyme bound nonspeciﬁcally. To
distinguish these possibilities, we reversed the order of addi-
tion: unlabeled sPLA2 was added before ﬂuorescamine-
labeled sPLA2 (Fig. 3D). A similar result was obtained when
we added unlabeled AppK49 sPLA2 before labeled enzyme
(not shown, results same as shown in Fig. 3D). Since labeled
sPLA2 appeared unable to bind in the presence of unlabeled
enzyme, we concluded that the ﬁrst possibility was more
likely: the observed adsorption of sPLA2 to cell membranes
was long-lived but speciﬁc.
The experiment of Fig. 3 was repeated multiple times on
cells treated with ionomycin or control vehicle (DMSO) at
37C. The concentration used in these experiments (67 nM)
was selected based on the kinetic results in Fig. 1 to optimize
potential sensitivity to ionomycin treatment while maintain-
ing a signal sufﬁciently large to measure. We assumed that if
ionomycin treatment caused either a large change in binding
afﬁnity or the number of adsorption sites, the difference
would be apparent at this concentration. The results were
quantiﬁed as described in Materials and Methods. The
measured adsorption was statistically signiﬁcant in both
cases (DMSO, 23 6 10% increase in ﬂuorescence intensity,
p¼ 0.04, n¼ 14; ionomycin, 276 6%, p ¼ 0.0003, n¼ 15,
one-sample t-tests) but were indistinguishable from each
other (p ¼ 0.74, unpaired t-test).
Since the data of Fig. 3 suggested that enzyme desorption
from the membrane surface was slow, we decided that a
centrifugation assay for adsorption could also be used in an
attempt to obtain data from bulk samples and allow analysis
at multiple temperatures. Repetition of the experiments
described in the previous paragraph with the centrifugation
assay validated the result that ionomycin treatment had no
effect on measured enzyme adsorption (not shown). Fig. 4
displays the temperature-dependence of enzyme adsorption
using the same assay (without ionomycin). Although the
temperature groups were distinguishable statistically (p ¼
0.04 by analysis of variance), no consistent trend with tem-
perature was observed. The apparently anomalous data at
FIGURE 3 Adsorption of ﬂuorescamine-labeled sPLA2 to erythrocytes at
37C. The experimental details of the two-photon microscopy and sample
preparation are explained in Materials and Methods. The images were ac-
quired before addition of labeled enzyme (A), 6 min after addition of 130-nM
labeled sPLA2 (B, same ﬁeld as A), 4 min later and 1 min after further
addition of 2.5 mM unlabeled sPLA2 (C, same ﬁeld as B). D is the image of
a fresh sample of erythrocytes 10 min after addition of 2.5-mM unlabeled
enzyme, which was added 9 min before 130-nM labeled enzyme.
FIGURE 4 Effect of temperature on the adsorption of ﬂuorescamine-
labeled sPLA2 to erythrocytes. The adsorption of 130-nM labeled sPLA2 to
erythrocytes was assayed by the centrifugation procedure described in
Materials and Methods at the indicated temperatures. The adsorption signals
in all ﬁve groups were signiﬁcant (p , 0.04, n ¼ 10, one-sample t-tests).
One-way analysis of variance comparing the groups was signiﬁcant (p ¼
0.04), although a Bonferoni post-test was unable to detect speciﬁc differ-
ences between any pairs of temperature groups.
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44C appeared to be entirely responsible for the statistical
signiﬁcance. Even if this group was ignored, no statistically
signiﬁcant trend was observed among the remaining data
(p ¼ 0.39 by linear regression and p ¼ 0.84 by analysis of
variance). We were unable to identify any explanation for the
44C data other than experimental variation. Taken together,
the adsorption data appeared to corroborate our conclusion
from the global analysis of hydrolysis kinetics that changes
in K1 provoked by calcium loading or temperature were
minimal.
The centrifugation assay allowed one additional beneﬁt;
an opportunity to estimate the approximate number of en-
zyme adsorption sites. The total potential number of binding
sites was determined by dividing the total surface area of an
erythrocyte by the surface area of the enzyme and suggested
that 8.5 3 106 enzymes would be bound per cell if the
surface were completely covered (Evans and Fung, 1972;
Arni and Ward, 1996). The average number of enzymes
adsorbed in all of our experiments at 130 nM sPLA2 was 2.0
6 0.3 3 105 sites/cell. Based on the data of Figs. 1 and 2,
;70% of the potential binding sites are occupied at that
concentration. Thus, at full occupancy, sPLA2 was estimated
to cover ;3% of the erythrocyte surface. This estimate
seemed reasonable based on a semiquantitative observation
from the two-photon microscopy. As a reference for com-
parison of the ﬂuorescence intensity, we labeled erythrocytes
directly with ﬂuorescamine. This manipulation presumably
labeled all membrane proteins. The intensity of cells thus
labeled was ;20-fold greater than that of adsorbed sPLA2
corroborating the conclusion that the enzyme adsorbs to only
a fraction of the cell membrane surface at saturation. These
results also served to validate the assumption that E ¼ ET in
the derivation of Eq. 8 (with 4 3 106 cells per sample, ,2%
of added enzyme molecules adsorbed to the cells at 130 nM).
Membrane lipid packing
If ionomycin treatment increases the ability of phospholipids
to migrate into the enzyme active site as suggested by the
kinetic results, it should decrease lipid packing, but only at
higher temperatures. We ﬁrst tested this prediction of the
hypothesis using MC540 ﬂuorescence. One challenge in
using MC540 with erythrocytes is that the probe does not
bind very well to the cell membrane (Lagerberg et al., 1995).
We overcame this challenge by obtaining three consecutive
spectra with each sample, one with aqueous MC540, one
after addition of and equilibration with, erythrocytes (;10–
20 min, depending on temperature), and one after addition of
ionomycin or DMSO. Data were analyzed as difference
spectra; the aqueous spectrum was subtracted from the
spectrum obtained after addition of erythrocytes and also
from the spectrum after addition of ionomycin or DMSO at
each temperature (hemoglobin absorption of light appeared
not to interfere at the wavelengths relevant to MC540). The
data were gathered using this method instead of prelabeling
and washing the cells before obtaining a spectrum as done in
previous studies because of the rapid dissociation of the dye
from the membrane after the washing step (Lagerberg et al.,
1995).
The difference spectra revealed peaks at 567 nm and 587
nm. The ratio of intensity at 567–587 was calculated for
erythrocytes before and after treatment with ionomycin. As
expected, elevation of temperature reduced the level of lipid
packing as shown by a modest reduction in the ratio of
intensity at 567–587 nm (not shown). The greatest tem-
perature sensitivity resided between 30 and 45C, consistent
with previous observations with the ﬂuorescent probe
laurdan (Best et al., 2002). Treatment of erythrocytes with
ionomycin further affected the apparent degree of packing as
a function of temperature (Fig. 5). At low temperatures,
ionomycin treatment caused the ratio of 567:587 nm to be
higher than the control, indicative of increased packing. How-
ever, at high temperature, the apparent level of packing was
greatly reduced by ionomycin treatment.
Lipid packing was further examined by considering the
ability of BSA to extract ﬂuorescent phospholipids from the
erythrocyte membranes. As shown in Fig. 6 A, the ﬂuo-
rescence intensity of NBD-PC was distinguishable depend-
ing on whether the probe was present as an aqueous
suspension, incorporated into cell membranes, or bound to
BSA. Consequently, addition of BSA to a suspension of cells
labeled with NBD-PC resulted in a time-dependent increase
in ﬂuorescence intensity (Fig. 6 B). Control experiments
using ﬂuorescence microscopy revealed that the addition of
BSA truly resulted in extraction of NBD-PC from cell
membranes (Fig. 7; note that the cells had been previously
washed to remove probe superﬁcially adsorbed). Experi-
ments in which BSA was added in the absence of NBD-PC
demonstrated that ;10% of the initial increase in apparent
ﬂuorescence intensity was an optical artifact that we were
able to quantify and subtract during the process of data
FIGURE 5 Effect of ionomycin treatment on the temperature-dependence
of MC540 ﬂuorescence in erythrocytes. The ratio of intensity at 567 nm to
intensity at 587 nm was calculated from difference spectra obtained from
samples before and after ionomycin treatment as described in Materials and
Methods. The data represent the ratio acquired before ionomycin treatment
subtracted from that obtained after ionomycin treatment.
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analysis (see Materials and Methods). Fig. 8 illustrates a
comparison in the kinetics of NBD-PC extraction from
erythrocytes treated with ionomycin and those treated with
the control diluent (DMSO). The more rapid rise in NBD
ﬂuorescence intensity observed in ionomycin-treated cells
was reproducible (DMSO, 0.045 6 0.003 s1, ionomycin,
0.057 6 0.005 s1, p ¼ 0.04, n ¼ 20, paired t-test).
Previous investigations identiﬁed a number of pharmaco-
logical manipulations that inhibit the various responses of
erythrocytes to ionomycin and differ as to whether they also
impair the effect of ionomycin to enhance susceptibility of
the cells to sPLA2 (Smith et al., 2001). The agents used were
EDTA, R5421, high extracellular KCl, phenylhydrazine, and
an inactive form of sPLA2, AppK49. EDTA inhibits re-
sponses to ionomycin by chelating extracellular calcium and
is therefore a useful control to identify whether observed
responses are due to calcium ﬂux as opposed to artifactual
effects of the ionophore. R5421 inhibits scramblase (Dekkers
et al., 1998), the calcium-activated transporter of phospho-
lipids, but does not interfere with ionomycin-induced sus-
ceptibility to sPLA2 (Smith et al., 2001). High extracellular
KCl prevents the shedding of microvesicles from the plasma
membrane in response to elevated intracellular calcium also
without impeding membrane hydrolysis (Smith et al., 2001).
In contrast, phenylhydrazine blocks ionomycin-induced sus-
ceptibility (Smith et al., 2001). AppK49 also inhibits the
action of sPLA2 (Wilson et al., 1999). However, instead of
impairing the effect of intracellular calcium to alter mem-
brane properties, AppK49 interferes with the adsorption of
active sPLA2 to the cell as explained above.
Fig. 9 illustrates the effects of these agents on the ability of
ionomycin to enhance the rate of extraction of NBD-PC from
erythrocytes by BSA. EDTA and phenylhydrazine repressed
the extraction rate difference between ionomycin-treated
cells and control samples. In contrast, neither high KCl nor
R5421 impaired the effect of ionomycin. In fact, the average
response appeared larger in the presence of R5421. Like-
wise, exposure of the cells to AppK49 had no effect on the
rate of NBD-PC extraction by BSA in the presence of
ionomycin.
As shown in Fig. 10, enhancement of the extraction rate
by ionomycin was most obvious at temperatures in the range
of 3540C (p ¼ 0.008). At low temperatures, between 22
FIGURE 6 Effect of binding to BSA on ﬂuorescence emission of NBD-
PC at 37C. (A) Fluorescence emission spectrum showing the intensity of an
aqueous suspension of NBD-PC (curve a), erythrocytes labeled with NBD-
PC (curve b, labeling details explained in Materials and Methods), and the
same labeled cells after incubation with BSA (curve c). (B) Time course of
ﬂuorescence intensity of erythrocytes labeled with NBD-PC before and after
addition of BSA (at the arrow).
FIGURE 7 Extraction of NBD-PC from erythrocytes by BSA imaged by
two-photon excitation microscopy. (A) Erythrocytes were labeled with
NBD-PC as described in Fig. 6, and imaged by two-photon microscopy at
39C. (B) An image of the same ﬁeld was obtained again immediately after
addition of BSA to the medium.
FIGURE 8 Effect of ionomycin on the initial rate of ﬂuorescence intensity
increase after addition of BSA. The experiment of Fig. 6 Bwas repeated with
cells that had been incubated 10 min with either DMSO (squares) or
ionomycin (triangles) before addition of BSA (t ¼ 0). The ﬂuorescence
intensity before addition of BSA was subtracted, and the data were normal-
ized to the intensity at 300 s.
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and 33C, the rate of phospholipid extraction was relatively
slow for both ionomycin and DMSO treatments, and no
difference between the groups was observed. Likewise, at
high temperatures (4148C) there was also no signiﬁcant
difference in rate of phospholipid extraction between iono-
mycin and DMSO-treated erythrocytes, apparently because
the rate in the control samples had reached that of samples
treated with ionophore. In fact, the upward turn from the
middle to the high temperature range was signiﬁcant by
linear regression (p ¼ 0.0003; 37.548C; n ¼ 14). In
contrast, no consistent trend was observed from 22 through
37C (p¼ 0.92, n¼ 19). As expected from the results shown
in Fig. 10, the effect of temperature across the entire range
was statistically signiﬁcant in the case of ionomycin
treatment (2237C, p ¼ 0.04, n ¼ 19; 37.548C, p ¼
0.004, n ¼ 15).
Extraction of phospholipids by sPLA2
If the results observed with BSA are relevant to enhancement
of step 2 in the reaction scheme, one would expect the same
behavior when sPLA2 is used to extract NBD-PC, and that
behavior should be reﬂective of the properties of the
enzyme’s active site. As shown in Fig. 11, when sPLA2
was used as the phospholipid acceptor (squares, Fig. 11 A),
similar changes in NBD intensity were observed although
they were not as large and occurred more slowly than with
BSA (Fig. 11 B). Replacement of calcium with barium
(2 mM) in the extracellular medium resulted in an absence of
change in NBD-PC ﬂuorescence upon addition of sPLA2 as
demonstrated in Fig. 11 A (triangles), implying that no
extraction had occurred. Under these conditions, barium
occupies the active site of sPLA2 and prevents formation of
the ternary complex with phospholipid (Dam-Mieras et al.,
1975; Yu et al., 1993a, 1998). Control experiments exam-
ining extraction by BSA in the presence of barium veriﬁed
that the effect of barium shown in Fig. 11 was speciﬁc for
sPLA2. Thus, the inhibition of phospholipid extraction by
barium argues that such extraction is directly relevant to the
binding of substrate to the enzyme active site.
Secretory PLA2 differs from BSA as an NBD-PC accepter
because it adsorbs to the membrane surface rather than
remaining free in solution and because it can hydrolyze
the ﬂuorescent phospholipid. To explore these issues,
we examined NBD-PC extraction from erythrocytes by
FIGURE 9 Effects of EDTA, R5421, KCl, phenylhydrazine, and K49
sPLA2 on the ability of ionomycin to promote an increased rate of NBD-PC
extraction. (A) Erythrocytes labeled with NBD-PC were incubated with
these test agents before addition of ionomycin or DMSO as explained in
Materials and Methods. NBD-PC extraction was assessed at least 5 min later
upon addition of BSA and normalized as in Fig. 8. Data represent the
arithmetic difference between samples treated with DMSO compared to
those treated with ionomycin within each group. Statistics (paired t-tests
comparing DMSO to ionomycin treatments assayed independently for each
group)—EDTA, p ¼ 0.53, n ¼ 8; KCl, p ¼ 0.02, n ¼ 8; R5421, p ¼ 0.03,
n¼ 8; and Phenylhydrazine, p¼ 0.61, n¼ 10. (B) Erythrocytes labeled with
NBD-PC were incubated 3 min with AppK49 (at the indicated concen-
trations) before addition of ionomycin. NBD-PC extraction was assessed at
least 5 min later upon addition of BSA. No statistical differences among the
data were observed based on analysis of variance (p ¼ 0.81, n ¼ 10–19).
FIGURE 10 Rate of NBD-PC extraction by BSA with and without
ionomycin at high, medium, and low temperatures. NBD-PC-labeled cells
were incubated at various temperatures with and without ionomycin and
then exposed to BSA as described in Materials and Methods. The data were
quantiﬁed and normalized as in Fig. 8. (Trials were grouped into temperature
categories as follows: high, 40–46C; medium, 33–39.5C; and low, 22–
32C.) Differences between ionomycin-treated and control groups were
signiﬁcant only in the medium temperature range (*p¼ 0.008, n¼ 9, paired
t-test). Data represent mean 6 SE.
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two-photon ﬂuorescence microscopy. The assumption was
that if the lipid were extracted by the enzyme but not
hydrolyzed, the extensive loss of ﬂuorescence from the mem-
brane observed with BSA (Fig. 7) would not occur since
the extracted lipid would remain bound to the enzyme on
the membrane surface. Alternatively, hydrolysis produces
NBD-labeled fatty acid which, due to its solubility in water,
would diffuse away from the membrane, resulting in ﬂuo-
rescence loss. Fig. 12 demonstrates that incubation of the
cells with sPLA2 caused loss of NBD-PC from the cell mem-
brane, indicating that hydrolysis was occurring. The extrac-
tion/hydrolysis took place over a time period from one to
several min and was faster at higher temperature (compare
Fig. 12, C and D to Fig. 12, A and B). Observation of the
same ﬁeld by light microscopy revealed that even though
most or all of the NBD-PC was removed at the higher tem-
peratures, the cells remained intact, suggesting that NBD-PC
was a better substrate for sPLA2 than the natural lipids.
We reasoned that the extraction and hydrolysis steps
would be distinguishable in bulk samples since each step
should cause opposite ﬂuorescence changes upon addition of
sPLA2 to NBD-PC-labeled erythrocytes. The extraction step
should result in enhanced NBD ﬂuorescence because NBD-
PC in the active site of sPLA2 is protected from water and
distanced from the autoquenching caused by other NBD-PC
molecules (Nichols and Pagano, 1981). Upon hydrolysis,
release of free NBD-fatty acid into the surrounding water
would reduce its emission intensity due to quenching by the
solvent. Thus, to quantify the effect of temperature on step
two (Scheme 1) using sPLA2, we assumed three possible
states of NBD-PC molecules: NBD-PC intercalated in the
membrane (Lm), NBD-PC bound to sPLA2 (LP), and NBD-
PC that has been hydrolyzed (LH). The other obvious
compartment, NBD-PC free in solution, was assumed to be
negligible. The ﬂuorescence level (F) represents the sum of
contributions from the various compartments,
F ¼ F0Lm1FPLP1FHLH; (10)
where F0 is the initial ﬂuorescence intensity when essentially
all NBD-PC is still present in the membrane, FP is the
ﬂuorescence intensity of NBD-PC bound to sPLA2, and FH
is the ﬂuorescence intensity of hydrolyzed NBD-PC. The
various species of NBD-PC would be expressed as mole
fractions. The differential equations describing the time-
dependence are
dLm
dt
¼ k2Lm (11)
FIGURE 11 Migration of NBD-PC into the active site of sPLA2 with
calcium or with barium compared to NBD-PC extraction with BSA. (A)
NBD-PC-labeled erythrocytes were prepared and incubated at 37C in nor-
mal MBSS (1.6 mM CaCl2, squares), or in low-calcium MBSS supple-
mented with BaCl2 (2 mM, triangles). At time zero on the graph, sPLA2
(70 nM) was added. (B) Display of data obtained as in Fig. 6 B for compari-
son purposes. BSA was added at time zero on the graph. In both A and B, the
ﬂuorescence intensity was normalized to the intensity of the ﬁrst datum after
addition of sPLA2 or BSA.
FIGURE 12 Two-photon microscopy images of the change in NBD-PC
ﬂuorescence in erythrocytes upon addition of sPLA2. Images were collected
as in Fig. 7. (A) Erythrocytes were treated 10 min with ionomycin at 25C.
(B) Same ﬁeld as A, 3 min after sPLA2 addition. (C) Erythrocyte treated
10 min with ionomycin at 42C. (D) Same ﬁeld as C, 3 min after sPLA2
addition.
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dLP
dt
¼ k2Lm  kcatLP: (12)
The rate constants k2 and kcat represent the kinetics of
extraction and hydrolysis, respectively. Integration of Eq. 11
followed by substitution into Eq. 12 and integration yields
the following expressions for Lm and LP:
Lm ¼ Lmð0Þek2t; (13)
LP ¼ k2Lmð0Þ
kcat  k2ðe
k2t  ekcattÞ: (14)
Since
LH ¼ Lmð0Þ  ðLm1 LPÞ (15)
is due to conservation of mass, substitution of Eqs. 13–15
into Eq. 10 provides a complete expression for the NBD-PC
ﬂuorescence during extraction and hydrolysis by sPLA2,
F ¼ a1bek2t1 gðek2t  ekcattÞ; (16)
where
a ¼ FHLmð0Þ
b ¼ ðF0  FHÞLmð0Þ
g ¼ ðFP  FHÞk2Lmð0Þðkcat  k2Þ : (17)
Fitting the data with Eq. 16 permitted calculation of the rate
constant for extraction (k2) and kcat from a series of
experiments at different temperatures (20–50C) in which
sPLA2 was used as the NBD-PC acceptor (with a, b, and g
treated as arbitrary ﬁtting constants). The value of k2 was
evaluated as a function of temperature by linear regression.
As was true for the rate of extraction with BSA, k2 increased
with temperature in ionomycin-treated erythrocytes from
0.026 s1 at 20C to 0.055 s1 at 47C (p ¼ 0.04, n ¼ 31).
The temperature trend for DMSO-treated samples was not
signiﬁcant (p ¼ 0.21, n ¼ 31). As expected (Best et al.,
2002), the hydrolysis step (kcat) also displayed signiﬁcant
temperature-dependence for both ionomycin-treated and
control samples (undetectable at 20C to 0.0004 s1 at
47C for ionomycin-treated samples, p # 0.0007 in both
cases, n ¼ 31).
DISCUSSION
This study was designed to test the hypothesis that physical
changes in erythrocyte membrane structure induced by
elevated intracellular calcium and temperature increase the
susceptibility of that membrane to sPLA2 by enhancing the
second step in the reaction scheme (Scheme 1). The kinetic
evidence (Figs. 1 and 2) strongly supported this hypothesis
and argued that calcium loading and temperature combine to
enhance hydrolysis by this mechanism. This argument
predicted that measurements of enzyme adsorption isolated
from the other steps in the reaction scheme should not reveal
much dependence on either temperature or calcium loading.
Although assessment of adsorption is difﬁcult to interpret
due to potential interaction with non-hydrolyzable sites on
the membrane (Ancian et al., 1995; Koduri et al., 1998), the
expected lack of temperature and ionomycin sensitivity was
apparent. In contrast, the hypothesis predicted that both iono-
phore treatment and elevation in temperature should cause
changes to the membrane representative of an increase in the
ability of phospholipids to move vertically in the membrane.
Assessment of lipid packing by MC540 ﬂuorescence and
extraction of NBD-PC provided evidence supporting the
conclusion that ionomycin treatment combined with elevated
temperature enhances the likelihood of vertical lipid mi-
gration. Thus, we conclude that induction of susceptibility
in erythrocytes by calcium loading occurs by enhancing the
second step in the reaction scheme.
A complexity in interpreting the data with NBD-PC was
that the observed changes in extraction rates among the
various experimental treatments were small compared to the
changes anticipated from the kinetic data. The primary
reason for this difﬁculty is the fact that NBD-PC is removed
much more readily from the membrane than are native
phospholipids. As shown in Fig. 7, all NBD-PC was re-
moved quickly from labeled cells upon introduction of BSA.
Since the cells remained intact during the extraction (based
on light microscopy), we conclude that the extraction ob-
served was preferential for NBD-labeled lipids. The in-
creased mobility of these lipids seems consistent with the
structure of NBD-PC since only one acyl chain inserts
deeply into the bilayer. The other chain, attached to the NBD
moiety, ﬂoats near the level of the glycerol backbone
(Chattopadhyay, 1990). Nevertheless, the data of Figs. 8 and
9 illustrate that the effect of ionomycin was reproducible and
consistent in each case with experimental conditions that do
or do not allow susceptibility to sPLA2.
The concept that the second step in Scheme 1 involves
migration of phospholipid molecules from their normal
position in the bilayer up into the active site of the bound
enzyme originated from studies with model bilayers.
Structural evaluation of sPLA2 suggests that the active site
of the adsorbed protein is not immersed in the bilayer (Scott
et al., 1990). Hence, there is a physical displacement between
the normal location of phospholipids in the membrane and
their binding site in the enzyme. Furthermore, kinetic studies
with polymerized lipids have indicated that catalysis is
ineffective if phospholipids are constrained from being able
to migrate upward from the plane of the bilayer (Wu and
Cho, 1993; Soltys et al., 1993). Functional analysis of the
hydrolysis of artiﬁcial membranes in the presence of various
perturbing agents has also demonstrated the need for two
distinct steps leading up to lipid catalysis (Burack and
Biltonen, 1994; Yu et al., 1993b; Jain et al., 1989; Henshaw
et al., 1998).
The proposal that step two would be the determining
distinction between resistant and susceptible cell membranes
was based on previous experiments with a ﬂuorescent
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membrane probe, laurdan. Those studies showed that
ionomycin-induced susceptibility corresponds to an increase
in the order ofmembrane lipids (Smith et al., 2001). However,
subsequent experiments in which temperature was varied
demonstrated that membrane order could not be the sole
determining factor because an increase in order caused by
lowered temperature resulted in reduced rather than enhanced
hydrolysis by sPLA2 (Best et al., 2002).Microscopic observa-
tions revealed a fundamental difference between adjusting
membrane order with temperature or with ionomycin
treatment. Temperature altered the membrane properties
homogeneously, whereas the ionophore increased order
heterogeneously. When ionomycin was added to the cells,
the original membrane properties relevant to the experimental
temperature were retained for much of the membrane, and
domains of ordered lipids were superimposed on that back-
ground. Thus, when temperature was .;35C, ionomycin
treatment produced sharp boundaries between ordered and
disordered membrane regions. Further increases in temper-
ature generatedmore heterogeneity and thusmore and sharper
domain boundaries. These effects appeared relevant to the
action of sPLA2 since membranes were most vulnerable to
hydrolysis upon addition of ionomycin at elevated temper-
ature (Fig. 2 and Best et al., 2002).
The MC540 data were useful in validating this in-
terpretation. MC540 ﬂuorescence is sensitive to the degree
of lipid packing in the membrane (Langner and Hui, 1993;
Lagerberg et al., 1995; Stillwell et al., 1993; Yu and Hui,
1992). Increasing membrane order homogeneously corre-
sponds to tighter packing as observed in artiﬁcial membranes
in the gel phase (Verkman, 1987; Langner and Hui, 1993;
Bernik and Disalvo, 1993). In contrast, a heterogeneous
increase in order creates a more complex effect on lipid
packing because the ordering effect would promote packing
whereas the proliferation of boundaries would diminish
packing. Thus, total MC540 ﬂuorescence observed for the
sample would represent a balance between these two phe-
nomena. If our hypothesis is correct, the heterogeneous
ordering produced by calcium loading would increase
packing at low temperature where the membrane is already
ordered. Alternatively, the sharp boundaries formed at high
temperature in the presence of ionophore could result in a net
decrease in packing if the size of the domains is small and the
number of boundaries therefore numerous. As shown in Fig.
5, these predicted results are exactly what were observed.
An alternative explanation that cannot be excluded by
existing data pertains to transbilayer rather than horizontal
heterogeneity in the membrane. Laurdan equilibrates across
the membrane and therefore would report properties of
both bilayer faces. The observed ﬂuorescence would be the
average of the two. Recent evidence argues that the effect of
intracellular calcium on membrane order may involve direct
binding of the cation to the interior of the cell membrane
(Vest et al., 2004). This effect would cause ordering of the
lipids on the inner face of the membrane resulting in
a unilateral decrease in membrane surface area. This event
would create strain on the outer face of the membrane since it
would try to match surface area with the inner leaﬂet.
MC540 would be preferentially exposed to this putative
strain since it does not cross the cell membrane readily and
would therefore bind only on the outer leaﬂet. This hypo-
thetical strain could also account for the increased extraction
and hydrolysis of ﬂuorescent phospholipids since vertical
migration of the lipids would be one way of relieving this
strain.
We propose that these results and interpretations reached
here with the simple membranes of erythrocytes apply to the
more complex bilayers of nucleated cells. Calcium loading
of various leukocyte cell lines also causes them to become
susceptible to sPLA2; in fact, the degree of gain in hydrolysis
is much greater than observed in erythrocytes (Wilson et al.,
1999). Physiologically, this phenomenon appears signiﬁcant
since cell membranes also become susceptible to the enzyme
early during hormone-stimulated apoptosis (Nielson et al.,
2000; Atsumi et al., 1997). Moreover, many of the phe-
nomena relevant to this report have also been observed with
human groups IIA and V sPLA2 (Wilson et al., 1999; Smith
et al., 2001). Accordingly, we propose that the simple hypo-
thesis examined here applies broadly to describe the ability
of sPLA2 to distinguish healthy and damaged cell mem-
branes.
Nevertheless, we do not intend to argue that step two is the
only limiting step for all sPLA2 species toward all healthy
cell membranes. Calcium entry during cell injury causes
exposure of the anionic phosphatidylserine in many cell
types similar to that observed during apoptosis (Bevers et al.,
1996). For many sPLA2 isoforms, such exposure of anionic
lipids can make a large difference in adsorption afﬁnity (Jain
et al., 1989; Henshaw et al., 1998; Koduri et al., 1998; Beers
et al., 2003). This appears to be especially true for the human
group IIA enzyme. Recent evidence suggests that it does not
adsorb to the cell membrane unless phosphatidylserine has
been exposed on the outer leaﬂet of the cell membrane
(Koduri et al., 1998; Beers et al., 2003). In contrast, the
ability of the human group V and snake venom enzymes to
distinguish resistant and susceptible membranes is un-
affected by pharmacological inhibition of phosphatidylserine
exposure (Smith et al., 2001). Furthermore, it appears that
protein receptors for sPLA2 can also offer protection against
the enzyme (Ancian et al., 1995). Given the obvious im-
portance of protecting healthy cell membranes from the
hydrolytic action of extracellular sPLA2, it seems reasonable
that multiple protective mechanisms would exist. We con-
clude that the results described here require that another
mechanism be added to the list. Future experiments will ad-
dress the relative importance of step two toward nucleated
cells and with the various human enzymes.
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